Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells
Our results highlight the potential of G28 as a therapeutic option for targeting LCSCs in both sensitive and resistant EGFRm NSCLC cells, though additional studies are required to validate these results and assess their clinical applicability.
Authors
- Joaquim Ciurana (ORCID: https://orcid.org/0000-0002-6574-5551)
- P. Sopena Novales
- Emma Polonio‐Alcalá (ORCID: https://orcid.org/0000-0003-1017-7216)
- Marta Planas (ORCID: https://orcid.org/0000-0003-4988-4970)
- Lídia Feliu (ORCID: https://orcid.org/0000-0001-9792-6106)
- Sira Ausellé‐Bosch (ORCID: https://orcid.org/0009-0005-8284-4657)
- Gerard Riesco-Llach (ORCID: https://orcid.org/0000-0002-9869-7488)
- Teresa Puig (ORCID: https://orcid.org/0000-0003-2715-7043)
Institutions
- Universitat de Girona (ES)
Publication Details
- Journal
- Lung Cancer Targets and Therapy
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/lctt.s512936
- Citations
- 2
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 2.09